Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The United Biomedical LHRH vaccine is a synthetic peptide-based vaccine designed for immunocastration and reproductive control in animals, particularly livestock. It targets luteinizing hormone-releasing hormone (LHRH), also known as gonadotropin-releasing hormone (GnRH). The vaccine works by inducing the production of antibodies that neutralize endogenous GnRH, thereby suppressing the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. This hormonal suppression leads to the inhibition of gonadal function, effectively achieving castration or reproductive control without surgical intervention. It is primarily used to manage boar taint in swine and control reproductive behaviors and fertility in various animal species, offering a more humane alternative to traditional surgical methods.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on United Biomedical LHRH vaccine.